View in EDS

Immune checkpoint inhibitors in patients with pre-existing psoriasis: safety and efficacy.

Saved in:
Bibliographic Details
Title: Immune checkpoint inhibitors in patients with pre-existing psoriasis: safety and efficacy.
Authors: Halle BR; Vanderbilt University School of Medicine, Nashville, Tennessee, USA briana.r.halle@vanderbilt.edu., Betof Warner A; Memorial Sloan Kettering Cancer Center, New York, New York, USA., Zaman FY; Alfred Hospital, Melbourne, Victoria, Australia., Haydon A; Department of Medical Oncology, Alfred Hospital, Melbourne, Victoria, Australia., Bhave P; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Dewan AK; Department of Dermatology, Vanderbilt University Medical Center, Nashville, Tennessee, USA., Ye F; Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee, USA., Irlmeier R; Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee, USA., Mehta P; Memorial Sloan Kettering Cancer Center, New York, New York, USA., Kurtansky NR; Memorial Sloan Kettering Cancer Center, New York, New York, USA., Lacouture ME; Memorial Sloan Kettering Cancer Center, New York, New York, USA., Hassel JC; Department of Dermatology, NCT, University Hospital Heidelberg, Heidelberg, Germany., Choi JS; Department of Medicine, Division of Hematology/Oncology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA., Sosman JA; Department of Medicine, Division of Hematology/Oncology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA., Chandra S; Department of Medicine, Division of Hematology/Oncology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA., Otto TS; Rutgers Robert Wood Johnson Medical School, Piscataway, New Jersey, USA.; Massachusetts General Hospital Cancer Center, Boston, Massachusetts, USA., Sullivan R; Massachusetts General Hospital Cancer Center, Boston, Massachusetts, USA., Mooradian MJ; Massachusetts General Hospital Cancer Center, Boston, Massachusetts, USA., Chen ST; Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts, USA., Dimitriou F; Melanoma Institute Australia, North Sydney, New South Wales, Australia.; Department of Dermatology, University Hospital Zurich, Zurich, Switzerland., Long G; Melanoma Institute Australia, North Sydney, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia., Carlino M; Melanoma Institute Australia, North Sydney, New South Wales, Australia.; Westmead Hospital, Westmead, New South Wales, Australia., Menzies A; Melanoma Institute Australia, North Sydney, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia., Johnson DB; Department of Medicine, Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, Tennessee, USA., Rotemberg VM; Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Source: Journal for immunotherapy of cancer [J Immunother Cancer] 2021 Oct; Vol. 9 (10).
Publication Type: Journal Article; Multicenter Study; Research Support, N.I.H., Extramural
Journal Info: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Print Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 34635495
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Immune checkpoint inhibitors in patients with pre-existing psoriasis: safety and efficacy.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Halle+BR%22">Halle BR</searchLink>; Vanderbilt University School of Medicine, Nashville, Tennessee, USA briana.r.halle@vanderbilt.edu.<br /><searchLink fieldCode="AU" term="%22Betof+Warner+A%22">Betof Warner A</searchLink>; Memorial Sloan Kettering Cancer Center, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Zaman+FY%22">Zaman FY</searchLink>; Alfred Hospital, Melbourne, Victoria, Australia.<br /><searchLink fieldCode="AU" term="%22Haydon+A%22">Haydon A</searchLink>; Department of Medical Oncology, Alfred Hospital, Melbourne, Victoria, Australia.<br /><searchLink fieldCode="AU" term="%22Bhave+P%22">Bhave P</searchLink>; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.<br /><searchLink fieldCode="AU" term="%22Dewan+AK%22">Dewan AK</searchLink>; Department of Dermatology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.<br /><searchLink fieldCode="AU" term="%22Ye+F%22">Ye F</searchLink>; Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.<br /><searchLink fieldCode="AU" term="%22Irlmeier+R%22">Irlmeier R</searchLink>; Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.<br /><searchLink fieldCode="AU" term="%22Mehta+P%22">Mehta P</searchLink>; Memorial Sloan Kettering Cancer Center, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Kurtansky+NR%22">Kurtansky NR</searchLink>; Memorial Sloan Kettering Cancer Center, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Lacouture+ME%22">Lacouture ME</searchLink>; Memorial Sloan Kettering Cancer Center, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Hassel+JC%22">Hassel JC</searchLink>; Department of Dermatology, NCT, University Hospital Heidelberg, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Choi+JS%22">Choi JS</searchLink>; Department of Medicine, Division of Hematology/Oncology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.<br /><searchLink fieldCode="AU" term="%22Sosman+JA%22">Sosman JA</searchLink>; Department of Medicine, Division of Hematology/Oncology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.<br /><searchLink fieldCode="AU" term="%22Chandra+S%22">Chandra S</searchLink>; Department of Medicine, Division of Hematology/Oncology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.<br /><searchLink fieldCode="AU" term="%22Otto+TS%22">Otto TS</searchLink>; Rutgers Robert Wood Johnson Medical School, Piscataway, New Jersey, USA.; Massachusetts General Hospital Cancer Center, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Sullivan+R%22">Sullivan R</searchLink>; Massachusetts General Hospital Cancer Center, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Mooradian+MJ%22">Mooradian MJ</searchLink>; Massachusetts General Hospital Cancer Center, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Chen+ST%22">Chen ST</searchLink>; Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Dimitriou+F%22">Dimitriou F</searchLink>; Melanoma Institute Australia, North Sydney, New South Wales, Australia.; Department of Dermatology, University Hospital Zurich, Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Long+G%22">Long G</searchLink>; Melanoma Institute Australia, North Sydney, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.<br /><searchLink fieldCode="AU" term="%22Carlino+M%22">Carlino M</searchLink>; Melanoma Institute Australia, North Sydney, New South Wales, Australia.; Westmead Hospital, Westmead, New South Wales, Australia.<br /><searchLink fieldCode="AU" term="%22Menzies+A%22">Menzies A</searchLink>; Melanoma Institute Australia, North Sydney, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.<br /><searchLink fieldCode="AU" term="%22Johnson+DB%22">Johnson DB</searchLink>; Department of Medicine, Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.<br /><searchLink fieldCode="AU" term="%22Rotemberg+VM%22">Rotemberg VM</searchLink>; Memorial Sloan Kettering Cancer Center, New York, New York, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101620585%22">Journal for immunotherapy of cancer</searchLink> [J Immunother Cancer] 2021 Oct; Vol. 9 (10).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Multicenter Study; Research Support, N.I.H., Extramural
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BMJ+Publishing+Group+Ltd%22">BMJ Publishing Group Ltd </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101620585 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2051-1426 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220511426%22">20511426 </searchLink><i>NLM ISO Abbreviation: </i>J Immunother Cancer <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34635495
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1136/jitc-2021-003066
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Immune checkpoint inhibitors in patients with pre-existing psoriasis: safety and efficacy.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Halle BR
      – PersonEntity:
          Name:
            NameFull: Betof Warner A
      – PersonEntity:
          Name:
            NameFull: Zaman FY
      – PersonEntity:
          Name:
            NameFull: Haydon A
      – PersonEntity:
          Name:
            NameFull: Bhave P
      – PersonEntity:
          Name:
            NameFull: Dewan AK
      – PersonEntity:
          Name:
            NameFull: Ye F
      – PersonEntity:
          Name:
            NameFull: Irlmeier R
      – PersonEntity:
          Name:
            NameFull: Mehta P
      – PersonEntity:
          Name:
            NameFull: Kurtansky NR
      – PersonEntity:
          Name:
            NameFull: Lacouture ME
      – PersonEntity:
          Name:
            NameFull: Hassel JC
      – PersonEntity:
          Name:
            NameFull: Choi JS
      – PersonEntity:
          Name:
            NameFull: Sosman JA
      – PersonEntity:
          Name:
            NameFull: Chandra S
      – PersonEntity:
          Name:
            NameFull: Otto TS
      – PersonEntity:
          Name:
            NameFull: Sullivan R
      – PersonEntity:
          Name:
            NameFull: Mooradian MJ
      – PersonEntity:
          Name:
            NameFull: Chen ST
      – PersonEntity:
          Name:
            NameFull: Dimitriou F
      – PersonEntity:
          Name:
            NameFull: Long G
      – PersonEntity:
          Name:
            NameFull: Carlino M
      – PersonEntity:
          Name:
            NameFull: Menzies A
      – PersonEntity:
          Name:
            NameFull: Johnson DB
      – PersonEntity:
          Name:
            NameFull: Rotemberg VM
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 10
              Text: 2021 Oct
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-electronic
              Value: 2051-1426
          Numbering:
            – Type: volume
              Value: 9
            – Type: issue
              Value: 10
          Titles:
            – TitleFull: Journal for immunotherapy of cancer
              Type: main
ResultId 1